The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Open accessAbstract
SUMMARY R-2-hydroxyglutarate (R-2HG), a metabolite produced by mutant isocitrate dehydrogenases (IDH), was recently reported to exhibit anti-tumor activity. However, its effect on cancer metabolism remains largely elusive. Here, unlike its reported inhibitory effect on ATP synthase in glioma, we show R-2HG mainly attenuates aerobic glycolysis, a hallmark of cancer metabolism, in (R-2HG-sensitive) leukemia cells. Mechanistically, R-2HG abrogates FTO/m6A/YTHDF2-mediated post-transcriptional upregulation of PFKP and LDHB (two critical glycolytic genes) expression, and thereby suppresses aerobic glycolysis. Knockdown of FTO, PFKP, or LDHB recapitulates R-2HG-induced glycolytic inhibition in (R-2HG-sensitive) leukemia cells but not normal CD34+ hematopoietic stem/progenitor cells, and inhibits leukemogenesis in vivo, while their overexpression reverses R-2HG-induced effects. R-2HG also suppresses glycolysis and downregulates FTO/PFKP/LDHB expression in human primary IDH-wildtype AML cells, demonstrating the clinical relevance. Collectively, our study reveals previously unrecognized effects of R-2HG and RNA modification on aerobic glycolysis in leukemia, highlighting the therapeutic potential of targeting cancer epitranscriptomics and metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Thorvaldsdottir, H., Robinson, J. T., & Mesirov, J. P. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbs017 · Cited by 9,049
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 1×
“An emerging hallmark of cancer is reprogramming of cellular metabolism (Hanahan and Weinberg, 2000, 2011; Hsu and Sabatini, 2008; Pavlova and Thompson, 2016).”
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Toward understanding the origin and evolution of cellular organisms
Kanehisa, M. (2019) · Protein Science · doi:10.1002/pro.3715 · Cited by 5,509 · cited 2×
“Pathways were enriched by hypergeometric test using KEGG metabolic pathway database (Kanehisa, 2019; Kanehisa and Goto, 2000).”
N6-methyladenosine-dependent regulation of messenger RNA stability
Wang, X., Lu, Z., Gomez, A., Hon, G. C., Yue, Y., Han, D., Fu, Y., Parisien, M., Dai, Q., Jia, G., et al. (2014) · Nature · doi:10.1038/nature12730 · Cited by 4,558
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Jia, G., Fu, Y., Zhao, X., Dai, Q., Zheng, G., Yang, Y., Yi, C., Lindahl, T., Pan, T., Yang, Y.-G., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.687 · Cited by 4,106
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Wang, X., Zhao, B. S., Roundtree, I. A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., & He, C. (2015) · Cell · doi:10.1016/j.cell.2015.05.014 · Cited by 3,483
A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1432 · Cited by 3,433
Self-citationA Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997
Self-citationXu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 1×
“An emerging hallmark of cancer is reprogramming of cellular metabolism (Hanahan and Weinberg, 2000, 2011; Hsu and Sabatini, 2008; Pavlova and Thompson, 2016).”
Understanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H., Sun, Z., Racevskis, J., Van Vlierberghe, P., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,946
YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA
Shi, H., Wang, X., Lu, Z., Zhao, B. S., Ma, H., Hsu, P. J., Liu, C., & He, C. (2017) · Cell Research · doi:10.1038/cr.2017.15 · Cited by 1,815
Lentivirus-delivered stable gene silencing by RNAi in primary cells
STEWART, S. A., DYKXHOORN, D. M., PALLISER, D., MIZUNO, H., YU, E. Y., AN, D. S., SABATINI, D. M., CHEN, I. S. Y., HAHN, W. C., SHARP, P. A., et al. (2003) · RNA · doi:10.1261/rna.2192803 · Cited by 1,582
Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome
Linder, B., Grozhik, A. V., Olarerin-George, A. O., Meydan, C., Mason, C. E., & Jaffrey, S. R. (2015) · Nature Methods · doi:10.1038/nmeth.3453 · Cited by 1,569
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Stein, E. M., DiNardo, C. D., Pollyea, D. A., Fathi, A. T., Roboz, G. J., Altman, J. K., Stone, R. M., DeAngelo, D. J., Levine, R. L., Flinn, I. W., et al. (2017) · Blood · doi:10.1182/blood-2017-04-779405 · Cited by 1,516
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase
Li, Z., Weng, H., Su, R., Weng, X., Zuo, Z., Li, C., Huang, H., Nachtergaele, S., Dong, L., Hu, C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.11.017 · Cited by 1,508
Self-citationDurable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML
DiNardo, C. D., Stein, E. M., de Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Swords, R., Collins, R. H., Mannis, G. N., Pollyea, D. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716984 · Cited by 1,454
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huang, H., Weng, H., & Chen, J. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.02.004 · Cited by 1,226
Self-citationTargeting lactate metabolism for cancer therapeutics
Doherty, J. R., & Cleveland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69741 · Cited by 1,166
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., Tsoi, J., Clark, O., Oldrini, B., Komisopoulou, E., et al. (2013) · Science · doi:10.1126/science.1236062 · Cited by 1,153
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Su, R., Dong, L., Li, C., Nachtergaele, S., Wunderlich, M., Qing, Y., Deng, X., Wang, Y., Weng, X., Hu, C., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.031 · Cited by 1,137
Self-citationReprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Hay, N. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.77 · Cited by 1,115
A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
Campeau, E., Ruhl, V. E., Rodier, F., Smith, C. L., Rahmberg, B. L., Fuss, J. O., Campisi, J., Yaswen, P., Cooper, P. K., & Kaufman, P. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006529 · Cited by 964
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Huang, Y., Su, R., Sheng, Y., Dong, L., Dong, Z., Xu, H., Ni, T., Zhang, Z. S., Zhang, T., Li, C., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.006 · Cited by 877
Self-citationRNA N6-methyladenosine modification in cancers: current status and perspectives
Deng, X., Su, R., Weng, H., Huang, H., Li, Z., & Chen, J. (2018) · Cell Research · doi:10.1038/s41422-018-0034-6 · Cited by 845
Self-citationTargeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
Wang, F., Travins, J., DeLaBarre, B., Penard-Lacronique, V., Schalm, S., Hansen, E., Straley, K., Kernytsky, A., Liu, W., Gliser, C., et al. (2013) · Science · doi:10.1126/science.1234769 · Cited by 804
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Su, R., Dong, L., Li, Y., Gao, M., Han, L., Wunderlich, M., Deng, X., Li, H., Huang, Y., Gao, L., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.017 · Cited by 763
Self-citationMetabolic Modulation of Glioblastoma with Dichloroacetate
Michelakis, E. D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E., Maguire, C., Gammer, T.-L., Mackey, J. R., Fulton, D., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000677 · Cited by 720
Dominissini, D., Moshitch-Moshkovitz, S., Salmon-Divon, M., Amariglio, N., & Rechavi, G. (2013) · Nature Protocols · doi:10.1038/nprot.2012.148 · Cited by 710
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
Huang, Y., Yan, J., Li, Q., Li, J., Gong, S., Zhou, H., Gan, J., Jiang, H., Jia, G.-F., Luo, C., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1276 · Cited by 662
The interplay between MYC and HIF in cancer
Dang, C. V., Kim, J.-W., Gao, P., & Yustein, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2274 · Cited by 613
Markert, C. L., Shaklee, J. B., & Whitt, G. S. (1975) · Science · doi:10.1126/science.1138367 · Cited by 562
Dawson, D. M., Goodfriend, T. L., Kaplan, N. O., & Kaplan, N. O. (1964) · Science · doi:10.1126/science.143.3609.929 · Cited by 548
Phan, L. M., Yeung, S. J., & Lee, M. H. (2014) · PubMed · doi:10.7497/j.issn.2095-3941.2014.01.001 · Cited by 490
Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
Chen, B., Ye, F., Yu, L., Jia, G., Huang, X., Zhang, X., Peng, S., Chen, K., Wang, M., Gong, S., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3064149 · Cited by 444
Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T., & Sonveaux, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00049 · Cited by 425
Enzymology of Cancer Cells: (Second of Two Parts)
Weber, G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703102961005 · Cited by 416
Isocitrate dehydrogenase mutations in myeloid malignancies
Medeiros, B. C., Fathi, A. T., DiNardo, C. D., Pollyea, D. A., Chan, S. M., & Swords, R. (2017) · Leukemia · doi:10.1038/leu.2016.275 · Cited by 350
Cell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis
Wang, Y.-H., Israelsen, W. J., Lee, D., Yu, V. W. C., Jeanson, N. T., Clish, C. B., Cantley, L. C., Vander Heiden, M. G., & Scadden, D. T. (2014) · Cell · doi:10.1016/j.cell.2014.07.048 · Cited by 348
Stein, E. M., DiNardo, C. D., Fathi, A. T., Pollyea, D. A., Stone, R. M., Altman, J. K., Roboz, G. J., Patel, M. R., Collins, R., Flinn, I. W., et al. (2019) · Blood · doi:10.1182/blood-2018-08-869008 · Cited by 331
Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis
Lee, J.-H., Liu, R., Li, J., Zhang, C., Wang, Y., Cai, Q., Qian, X., Xia, Y., Zheng, Y., Piao, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00906-9 · Cited by 314
The pentose cycle and insulin release in mouse pancreatic islets
Ashcroft, S. J. H., Weerasinghe, L. C. C., Bassett, J. M., & Randle, P. J. (1972) · Biochemical Journal · doi:10.1042/bj1260525 · Cited by 301
The prognostic significance of IDH2 mutations in AML depends on the location of the mutation
Green, C. L., Evans, C. M., Zhao, L., Hills, R. K., Burnett, A. K., Linch, D. C., & Gale, R. E. (2011) · Blood · doi:10.1182/blood-2010-12-322479 · Cited by 268
Chapter 17 Messenger RNA Half‐Life Measurements in Mammalian Cells
Chen, C. A., Ezzeddine, N., & Shyu, A. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(08)02617-7 · Cited by 256
Self-citationüber den Stoffwechsel der Carcinomzelle
Warburg, O. (1925) · Klinische Wochenschrift · doi:10.1007/bf01726151 · Cited by 253
Wang, J., Li, Y., Wang, P., Han, G., Zhang, T., Chang, J., Yin, R., Shan, Y., Wen, J., Xie, X., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.04.001 · Cited by 243
Self-citationMYC and tumor metabolism: chicken and egg
Dejure, F. R., & Eilers, M. (2017) · The EMBO Journal · doi:10.15252/embj.201796438 · Cited by 240
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling
Fu, X., Chin, R. M., Vergnes, L., Hwang, H., Deng, G., Xing, Y., Pai, M. Y., Li, S., Ta, L., Fazlollahi, F., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.009 · Cited by 235
Self-citationLactate Dehydrogenase B Controls Lysosome Activity and Autophagy in Cancer
Brisson, L., Bański, P., Sboarina, M., Dethier, C., Danhier, P., Fontenille, M.-J., Van Hée, V. F., Vazeille, T., Tardy, M., Falces, J., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.08.005 · Cited by 229
Li, Z., Herold, T., He, C., Valk, P. J. M., Chen, P., Jurinovic, V., Mansmann, U., Radmacher, M. D., Maharry, K. S., Sun, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.3184 · Cited by 206
Self-citationKim, N. H., Cha, Y. H., Lee, J., Lee, S.-H., Yang, J. H., Yun, J. S., Cho, E. S., Zhang, X., Nam, M., Kim, N., et al. (2017) · Nature Communications · doi:10.1038/ncomms14374 · Cited by 204
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival
Pathria, G., Scott, D. A., Feng, Y., Lee, J. S., Fujita, Y., Zhang, G., Sahu, A. D., Ruppin, E., Herlyn, M., Osterman, A. L., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899735 · Cited by 171
Rodriguez, S., Jafer, O., Goker, H., Summersgill, B. M., Zafarana, G., Gillis, A. J. M., van Gurp, R. J. H. L. M., Oosterhuis, J. W., Lu, Y.-J., Huddart, R., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206302 · Cited by 168
Herold, T., Jurinović, V., Batcha, A. M. N., Bamopoulos, S. A., Rothenberg‐Thurley, M., Ksienzyk, B., Hartmann, L., Greif, P. A., Philippou‐Massier, J., Krebs, S., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.178442 · Cited by 153
Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy
Kanno, T., Sudo, K., Maekawa, M., Nishimura, Y., UKITA, M., & Fukutake, K. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90359-2 · Cited by 149
Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas
McCleland, M. L., Adler, A. S., Deming, L., Cosino, E., Lee, L. B., Blackwood, E. M., Solon, M., Tao, J., Li, L., Shames, D. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2638 · Cited by 149
Wang, T., Hong, T., Huang, Y., Su, H., Wu, F., Chen, Y., Wei, L., Huang, W., Hua, X., Yu, X., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b06690 · Cited by 145
Spitz, G. A., Furtado, C. M., Sola‐Penna, M., & Zancan, P. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.020 · Cited by 135
Hereditary deficiency of lactate dehydrogenase M-subunit
Takashi, K., Sudo, K., Izumi, T., Shinji, K., Honda, N., Nishimura, Y., & Kunio, O. (1980) · Clinica Chimica Acta · doi:10.1016/0009-8981(80)90013-3 · Cited by 134
Cheng, A., Zhang, P., Wang, B., Yang, D., Duan, X., Jiang, Y., Tian, X., Jiang, Y. P., Shi, J., Ding, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13485-8 · Cited by 134
Moon, J., Kim, H., Koh, E., Park, S., Jin, W.-J., Park, B., Park, S. W., & Kim, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236737 · Cited by 132
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer
Leiblich, A., Cross, S. S., Catto, J. W. F., Phillips, J. T., Leung, H. Y., Hamdy, F. C., & Rehman, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209262 · Cited by 125
Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
Dennison, J. B., Molina, J. R., Mitra, S., Gonzalez-Angulo, A. M., Balko, J. M., Kuba, M. G., Sanders, M. E., Pinto, J. A., Gómez, H., Arteaga, C. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0623 · Cited by 117
Overexpression and knockout of miR-126 both promote leukemogenesis
Li, Z., Chen, P., Su, R. J., Li, Y., Hu, C., Wang, Y., Arnovitz, S., He, M., Gurbuxani, S. K., Zuo, Z., et al. (2015) · Blood · doi:10.1182/blood-2015-04-639062 · Cited by 112
Self-citationPHYSICOCHEMICAL NATURE OF ISOZYMES*
Markert, C. L., & Appella, E. (1961) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1961.tb35565.x · Cited by 110
PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism
Lang, L., Chemmalakuzhy, R., Shay, C., & Teng, Y. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_13 · Cited by 105
Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells
Murphy, T. A., Dang, C. V., & Young, J. D. (2012) · Metabolic Engineering · doi:10.1016/j.ymben.2012.07.008 · Cited by 92
RNA Modifications in Cancer: Functions, Mechanisms, and Therapeutic Implications
Huang, H., Weng, H., Deng, X., & Chen, J. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033357 · Cited by 92
Self-citationTandon, P., Gallo, C. A., Khatri, S., Barger, J. F., Yepiskoposyan, H., & Plas, D. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013629108 · Cited by 77
Self-citationWunderlich, M., Brooks, R. A., Panchal, R., Rhyasen, G. W., Danet-Desnoyers, G. A., & Mulloy, J. C. (2014) · Blood · doi:10.1182/blood-2014-02-556340 · Cited by 72
Sánchez-Martínez, C., & Aragón, J. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00496-1 · Cited by 69
Promoter Hypermethylation in Cancer Silences LDHB, Eliminating Lactate Dehydrogenase Isoenzymes 1-4
Maekawa, M., Taniguchi, T., Ishikawa, J., Sugimura, H., Sugano, K., & Kanno, T. (2003) · Clinical Chemistry · doi:10.1373/49.9.1518 · Cited by 54
Riquelme, P. T., Wernette-Hammond, M. E., Kneer, N. M., & Lardy, H. A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42964-4 · Cited by 42
MYC, Metabolic Synthetic Lethality, and Cancer
Hsieh, A. L., & Dang, C. V. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_4 · Cited by 38
A more universal and stable method for lactate dehydrogenase isoenzyme test
Li, P., Qiu, N., Zhang, L., Zhong, G., & Zeng, F. (2019) · Analytical Methods · doi:10.1039/c9ay01327j · Cited by 7
Cited by
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
Self-citationThe roles and implications of RNA m6A modification in cancer
Deng, X., Qing, Y., Horne, D., Huang, H., & Chen, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00774-x · Cited by 364
Self-citationWeng, H., Huang, F., Yu, Z., Chen, Z., Prince, E., Kang, Y., Zhou, K., Li, W., Hu, J., Fu, C., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.10.004 · Cited by 336
Self-citationFTO mediates LINE1 m 6 A demethylation and chromatin regulation in mESCs and mouse development
Wei, J., Yu, X., Yang, L., Liu, X., Gao, B., Huang, B., Dou, X., Liu, J., Zou, Z., Cui, X.-L., et al. (2022) · Science · doi:10.1126/science.abe9582 · Cited by 294
Self-citationLu, S., Han, L., Hu, X., Sun, T., Xu, D., Li, Y., Chen, Q., Yao, W., He, M., Wang, Z., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01204-0 · Cited by 116
Self-citation
Metadata
- Authors
- Qing, Y., Dong, L., Gao, L., Li, C., Li, Y., Han, L., Prince, E., Tan, B., Deng, X., Wetzel, C., Shen, C., Gao, M., Chen, Z., Li, W., Zhang, B., Braas, D., ten Hoeve, J., Sanchez, G. J., Chen, H., Chan, L. N., Chen, C.-W., Ann, D., Jiang, L., Müschen, M., Marcucci, G., Plas, D. R., Li, Z., Su, R., & Chen, J.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 81
- Issue
- 5
- Pages
- 922-939.e9
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W3119486198
- Cited by
- 330
- References
- 94
- FWCI
- 21.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.